Skip to article frontmatterSkip to article content
Site not loading correctly?

This may be due to an incorrect BASE_URL configuration. See the MyST Documentation for reference.

Time Series Analysis: Trends in Health Indicators and Gender Gaps (2000-2019)

Purpose

This report examines temporal trends in health indicators and gender gaps across OECD countries from 2000 to 2019. By analyzing data across all years in this period, we can observe:

This temporal analysis complements the cross-sectional modeling approach by revealing dynamic patterns that may not be apparent in single-year snapshots. Understanding these trends helps identify:

Methodology

Data Sources and Time Period

Data Processing

For each indicator, we:

  1. Load temporal data: Preserve all years from 2000-2019 (not just the most recent year)

  2. Compute gender gaps: For each year, calculate the difference between male and female values

    • For predictors: Gap = Male - Female (positive gap means higher male rates)

    • For targets (HALE/LE): Gap = Female - Male (positive gap means women live longer)

  3. Compute midpoint values: Average of male and female values, representing overall rates

  4. Filter to OECD countries: Focus on 38 OECD countries for consistency and data quality

Statistical Analysis

For each indicator and country, we compute:

For each indicator, we identify countries with:

HALE and Life Expectancy

HALE Time Series (Overall Rates)

The following figures show changes in HALE in all countries and in selected countries.

HALE Over Time (2000-2019) - All OECD Countries

Figure 1:HALE Over Time (2000-2019) - All OECD Countries

HALE Over Time (2000-2019) - Selected Countries

Figure 2:HALE Over Time (2000-2019) - Selected Countries

Key Observations:

Life Expectancy Time Series (Overall Rates)

The following figures show changes in life expectancy in all countries and in selected countries.

Life Expectancy Over Time (2000-2019) - All OECD Countries

Figure 3:Life Expectancy Over Time (2000-2019) - All OECD Countries

Life Expectancy Over Time (2000-2019) - Selected Countries

Figure 4:Life Expectancy Over Time (2000-2019) - Selected Countries

Key Observations:

Relationship between Levels and Gaps:

The HALE gap represents the difference in Healthy Life Expectancy between women and men (Female - Male, in years). A positive gap means women have longer healthy life expectancy.

HALE Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 5:HALE Gender Gap Over Time (2000-2019) - All OECD Countries

The figure above shows HALE gap trends for all OECD countries. Several patterns are evident:

HALE Gender Gap Over Time (2000-2019) - Selected Countries

Figure 6:HALE Gender Gap Over Time (2000-2019) - Selected Countries

The selected countries view highlights key examples:

The Life Expectancy gap represents the difference in overall Life Expectancy between women and men (Female - Male, in years).

Life Expectancy Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 7:Life Expectancy Gender Gap Over Time (2000-2019) - All OECD Countries

Life Expectancy Gender Gap Over Time (2000-2019) - Selected Countries

Figure 8:Life Expectancy Gender Gap Over Time (2000-2019) - Selected Countries

Life Expectancy gaps show similar patterns to HALE gaps, but are generally larger (since they include years lived in poor health). The OECD average shows a gradual narrowing trend over the two-decade period.

Value Changes: 2000 to 2019

The following table shows how HALE values changed for each country over the two-decade period:

CountryHALE 2000HALE 2019Change
Japan7173.52.52
South Korea66.572.45.91
Spain68.971.72.78
Switzerland68.371.53.21
Israel68.371.53.17
Luxembourg67.871.43.65
Sweden69.271.42.17
Italy68.371.43.06
Iceland69.171.42.26
Norway67.871.23.37
Netherlands6871.13.02
France6870.72.73
Ireland66.370.54.15
Austria67.570.42.88
Denmark66.670.33.68
Canada68.570.31.78
Australia68.170.32.16
Slovenia65.970.24.33
Finland66.870.23.37
Belgium67.270.12.9
Portugal66703.97
Greece67.869.82.05
New Zealand67.269.72.49
United Kingdom67.269.72.49
Germany67.469.42.05
Chile66.269.33.12
Costa Rica67.969.21.36
Czechia65.368.53.19
Estonia61.868.26.39
Colombia63.467.94.51
Poland64.267.53.38
Slovakia63.967.43.59
Türkiye63.667.23.56
Hungary62.266.54.31
Lithuania62.566.13.63
United States65.3660.74
Latvia61.165.94.75
Mexico64.165.51.37

The following table shows how Life Expectancy values changed for each country over the two-decade period:

CountryLife Expectancy 2000Life Expectancy 2019Change
Japan81.484.42.99
South Korea75.883.67.77
Switzerland79.683.43.82
Spain79.183.14.01
Italy79.382.93.65
Luxembourg78.382.84.47
Sweden79.582.73.17
Australia79.782.72.96
Norway78.582.64.14
Israel78.582.54.05
Iceland79.782.52.82
France78.982.53.59
Netherlands77.982.34.36
Canada79822.98
Ireland76.481.95.5
New Zealand78.581.83.27
Finland77.581.64.12
Austria7881.63.57
Belgium77.681.63.94
Slovenia7681.35.35
Denmark76.981.34.38
Portugal76.681.34.69
United Kingdom77.881.23.42
Chile76.8814.24
Germany78812.99
Greece78.580.92.44
Costa Rica78.280.32.1
Czechia7579.14.12
United States76.678.82.15
Estonia70.978.77.74
Colombia72.677.95.3
Poland73.777.74.03
Türkiye73.477.64.23
Slovakia73.377.64.25
Hungary71.476.24.88
Lithuania71.976.14.2
Mexico74.275.81.63
Latvia70.175.55.38

Key Findings from Value Changes:

Gap Changes: 2000 to 2019

The following table shows how HALE gaps changed for each country over the two-decade period:

CountryGap 2000Gap 2019Change
Lithuania7.536.06-1.47
Latvia7.985.69-2.29
Poland5.664.93-0.73
Estonia7.474.79-2.68
Slovakia5.363.93-1.43
Hungary5.583.72-1.86
South Korea4.913.56-1.35
Mexico2.363.10.74
Czechia4.243.09-1.15
Japan4.152.93-1.22
Slovenia4.72.91-1.79
Colombia5.332.89-2.43
Portugal3.572.39-1.18
Costa Rica2.072.260.19
Finland3.862.24-1.61
France3.51.82-1.68
United States2.191.8-0.39
Spain3.651.52-2.13
Chile2.391.41-0.98
Austria2.921.36-1.55
Greece2.021.33-0.69
Canada2.051.25-0.8
Türkiye3.261.17-2.09
Australia2.391.16-1.22
Italy2.561.07-1.49
Belgium2.90.94-1.96
Luxembourg2.810.91-1.9
Denmark1.590.89-0.7
Germany2.350.86-1.49
United Kingdom1.750.69-1.06
Israel1.410.61-0.8
New Zealand2.060.49-1.58
Ireland2.260.45-1.81
Switzerland2.50.34-2.16
Norway2.470.24-2.23
Iceland0.980.16-0.82
Sweden1.510.13-1.38
Netherlands1.780.02-1.76

The following table shows how Life Expectancy gaps changed for each country over the two-decade period:

CountryGap 2000Gap 2019Change
Lithuania10.79.36-1.33
Latvia118.92-2.09
Estonia10.67.92-2.66
Poland8.377.55-0.81
Slovakia8.176.67-1.5
Hungary8.546.54-1.99
Mexico4.966.091.13
South Korea7.116.01-1.1
Portugal7.015.77-1.24
Czechia6.755.63-1.12
Slovenia7.555.47-2.08
Japan6.725.45-1.27
France7.285.38-1.9
Colombia85.22-2.78
Spain6.795.12-1.66
Finland6.785.04-1.74
Türkiye7.55.04-2.47
Costa Rica4.764.780.03
Chile5.764.68-1.08
United States4.94.45-0.45
Germany5.884.44-1.44
Austria5.894.33-1.56
Greece4.994.21-0.78
Belgium6.24.15-2.05
Italy5.743.98-1.76
Luxembourg5.923.92-2
Australia5.123.85-1.27
Canada5.023.77-1.25
Israel4.293.58-0.71
Denmark4.473.57-0.89
United Kingdom4.63.42-1.18
Switzerland5.453.36-2.09
Ireland5.123.33-1.8
New Zealand5.063.27-1.79
Sweden4.53.07-1.43
Norway5.293.04-2.25
Netherlands4.912.91-1.99
Iceland3.922.8-1.12

Key Findings from Gap Changes:

Relationship between Value and Gap Changes:

Summary

Overall Values (HALE and Life Expectancy)

TargetHighest Mean CountryHighest Mean ValueLowest Mean CountryLowest Mean ValueHighest Slope CountryHighest Slope ValueLowest Slope CountryLowest Slope Value
HALEJapan72.3Latvia63.4Estonia0.367United States0.0474
Life ExpectancyJapan83Latvia72.5Estonia0.443Mexico0.0851

Gender Gaps (HALE Gap and Life Expectancy Gap)

TargetHighest Mean CountryHighest Mean ValueLowest Mean CountryLowest Mean ValueHighest Slope CountryHighest Slope ValueLowest Slope CountryLowest Slope Value
HALE GapLithuania7.5Iceland0.501Mexico0.0452Estonia-0.173
Life Expectancy GapLithuania11Iceland3.28Mexico0.0648Estonia-0.175

This section examines temporal trends for each of the 10 health indicators used in the predictive models. For each indicator, we show:

  1. Overall rates (Mid values): Average of male and female rates, representing the overall mortality burden

  2. Gender gaps (Gap values): Difference between male and female rates (Male - Female)

Alcohol Use Disorders

Alcohol use disorders represent deaths directly attributable to alcohol consumption.

Alcohol Use Disorders Death Rate Over Time (2000-2019) - All OECD Countries

Figure 9:Alcohol Use Disorders Death Rate Over Time (2000-2019) - All OECD Countries

Alcohol Use Disorders Death Rate Over Time (2000-2019) - Selected Countries

Figure 10:Alcohol Use Disorders Death Rate Over Time (2000-2019) - Selected Countries

Alcohol Use Disorders Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 11:Alcohol Use Disorders Gender Gap Over Time (2000-2019) - All OECD Countries

Alcohol Use Disorders Gender Gap Over Time (2000-2019) - Selected Countries

Figure 12:Alcohol Use Disorders Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Cardiovascular Disease

Cardiovascular disease is one of the leading causes of death globally.

Cardiovascular Disease Death Rate Over Time (2000-2019) - All OECD Countries

Figure 13:Cardiovascular Disease Death Rate Over Time (2000-2019) - All OECD Countries

Cardiovascular Disease Death Rate Over Time (2000-2019) - Selected Countries

Figure 14:Cardiovascular Disease Death Rate Over Time (2000-2019) - Selected Countries

Cardiovascular Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 15:Cardiovascular Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Cardiovascular Disease Gender Gap Over Time (2000-2019) - Selected Countries

Figure 16:Cardiovascular Disease Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Chronic Respiratory Disease

Chronic respiratory diseases include conditions like COPD and asthma.

Chronic Respiratory Disease Death Rate Over Time (2000-2019) - All OECD Countries

Figure 17:Chronic Respiratory Disease Death Rate Over Time (2000-2019) - All OECD Countries

Chronic Respiratory Disease Death Rate Over Time (2000-2019) - Selected Countries

Figure 18:Chronic Respiratory Disease Death Rate Over Time (2000-2019) - Selected Countries

Chronic Respiratory Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 19:Chronic Respiratory Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Chronic Respiratory Disease Gender Gap Over Time (2000-2019) - Selected Countries

Figure 20:Chronic Respiratory Disease Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Suicide (Self-Harm)

Suicide represents intentional self-harm deaths.

Suicide Death Rate Over Time (2000-2019) - All OECD Countries

Figure 21:Suicide Death Rate Over Time (2000-2019) - All OECD Countries

Suicide Death Rate Over Time (2000-2019) - Selected Countries

Figure 22:Suicide Death Rate Over Time (2000-2019) - Selected Countries

Suicide Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 23:Suicide Gender Gap Over Time (2000-2019) - All OECD Countries

Suicide Gender Gap Over Time (2000-2019) - Selected Countries

Figure 24:Suicide Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Homicide (Interpersonal Violence)

Homicide represents deaths from intentional interpersonal violence.

Homicide Death Rate Over Time (2000-2019) - All OECD Countries

Figure 25:Homicide Death Rate Over Time (2000-2019) - All OECD Countries

Homicide Death Rate Over Time (2000-2019) - Selected Countries

Figure 26:Homicide Death Rate Over Time (2000-2019) - Selected Countries

Homicide Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 27:Homicide Gender Gap Over Time (2000-2019) - All OECD Countries

Homicide Gender Gap Over Time (2000-2019) - Selected Countries

Figure 28:Homicide Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Road Traffic Injuries

Road traffic injuries represent deaths from motor vehicle accidents.

Road Traffic Injury Death Rate Over Time (2000-2019) - All OECD Countries

Figure 29:Road Traffic Injury Death Rate Over Time (2000-2019) - All OECD Countries

Road Traffic Injury Death Rate Over Time (2000-2019) - Selected Countries

Figure 30:Road Traffic Injury Death Rate Over Time (2000-2019) - Selected Countries

Road Traffic Injury Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 31:Road Traffic Injury Gender Gap Over Time (2000-2019) - All OECD Countries

Road Traffic Injury Gender Gap Over Time (2000-2019) - Selected Countries

Figure 32:Road Traffic Injury Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Liver Disease

Liver disease includes deaths from cirrhosis, hepatitis, and other liver conditions.

Liver Disease Death Rate Over Time (2000-2019) - All OECD Countries

Figure 33:Liver Disease Death Rate Over Time (2000-2019) - All OECD Countries

Liver Disease Death Rate Over Time (2000-2019) - Selected Countries

Figure 34:Liver Disease Death Rate Over Time (2000-2019) - Selected Countries

Liver Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 35:Liver Disease Gender Gap Over Time (2000-2019) - All OECD Countries

Liver Disease Gender Gap Over Time (2000-2019) - Selected Countries

Figure 36:Liver Disease Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Neoplasms (Cancer)

Neoplasms represent deaths from all types of cancer.

Cancer Death Rate Over Time (2000-2019) - All OECD Countries

Figure 37:Cancer Death Rate Over Time (2000-2019) - All OECD Countries

Cancer Death Rate Over Time (2000-2019) - Selected Countries

Figure 38:Cancer Death Rate Over Time (2000-2019) - Selected Countries

Cancer Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 39:Cancer Gender Gap Over Time (2000-2019) - All OECD Countries

Cancer Gender Gap Over Time (2000-2019) - Selected Countries

Figure 40:Cancer Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Unintentional Injuries

Unintentional injuries include deaths from accidents not classified elsewhere (falls, poisonings, etc.).

Unintentional Injury Death Rate Over Time (2000-2019) - All OECD Countries

Figure 41:Unintentional Injury Death Rate Over Time (2000-2019) - All OECD Countries

Unintentional Injury Death Rate Over Time (2000-2019) - Selected Countries

Figure 42:Unintentional Injury Death Rate Over Time (2000-2019) - Selected Countries

Unintentional Injury Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 43:Unintentional Injury Gender Gap Over Time (2000-2019) - All OECD Countries

Unintentional Injury Gender Gap Over Time (2000-2019) - Selected Countries

Figure 44:Unintentional Injury Gender Gap Over Time (2000-2019) - Selected Countries

Key Observations:

Diabetes

Diabetes represents deaths from diabetes mellitus (primarily type 2).

Diabetes Death Rate Over Time (2000-2019) - All OECD Countries

Figure 45:Diabetes Death Rate Over Time (2000-2019) - All OECD Countries

Diabetes Death Rate Over Time (2000-2019) - Selected Countries

Figure 46:Diabetes Death Rate Over Time (2000-2019) - Selected Countries

Diabetes Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 47:Diabetes Gender Gap Over Time (2000-2019) - All OECD Countries

Diabetes Gender Gap Over Time (2000-2019) - All OECD Countries

Figure 48:Diabetes Gender Gap Over Time (2000-2019) - All OECD Countries

Key Observations:

Summary: Indicator Superlatives

The following tables summarize which countries have the highest and lowest means and slopes for each indicator, providing insights into:

  1. Which countries have the best/worst outcomes (highest/lowest means)

  2. Which countries are improving most/least (highest/lowest slopes)

Overall Rates (Mid Values)

IndicatorHighest Mean CountryHighest Mean ValueLowest Mean CountryLowest Mean ValueHighest Slope CountryHighest Slope ValueLowest Slope CountryLowest Slope Value
AlcoholEstonia19.7Colombia0.196Slovenia0.341Estonia-0.889
CardiovascularLatvia784Mexico108Lithuania8.35Estonia-11.1
ChronicRespiratoryDenmark78.9Latvia17.2Hungary1.52Lithuania-0.507
SuicideLithuania41.7Türkiye2.71South Korea0.352Lithuania-0.977
HomicideColombia46.2Japan0.634Mexico1Colombia-2.91
RoadTrafficLithuania17.5Sweden4.44Costa Rica0.00107Latvia-1.06
LiverDiseaseHungary49Iceland3.27Lithuania0.394Hungary-1.85
NeoplasmsHungary342Mexico69.1Japan5.69Luxembourg-2.02
UnintentionalInjuryLithuania57.1Türkiye11.9Netherlands1.04Estonia-2.35
DiabetesMexico44.1Japan6.43Czechia1.71Israel-0.786

Key Insights from Rates Summary:

Gender Gaps (Gap Values)

IndicatorHighest Mean CountryHighest Mean ValueLowest Mean CountryLowest Mean ValueHighest Slope CountryHighest Slope ValueLowest Slope CountryLowest Slope Value
AlcoholEstonia25.3Colombia0.297Slovenia0.596Estonia-0.9
CardiovascularCosta Rica22.9Austria-94.9Germany4.62Lithuania-4.21
ChronicRespiratorySpain35.3Iceland-12.2Japan0.857Belgium-1.21
SuicideLithuania57.5Türkiye2.87South Korea0.467Lithuania-1.35
HomicideColombia75.3Switzerland0.0575Mexico1.59Colombia-4.69
RoadTrafficCosta Rica21.1Iceland3.07Colombia0.14Latvia-1.22
LiverDiseaseHungary44.9Iceland1.07Lithuania0.459Hungary-1.88
NeoplasmsJapan129Mexico0.609Portugal1.86Hungary-2.09
UnintentionalInjuryLithuania63.3Netherlands-6.44Denmark0.234Estonia-3.29
DiabetesDenmark3.54Portugal-8.27Germany0.544South Korea-0.343

Key Insights from Gaps Summary:

Key Findings and Conclusions

  1. Gender gaps are narrowing: Both HALE and Life Expectancy gaps show gradual narrowing trends across OECD countries, suggesting overall improvement in gender equity in health outcomes.

  2. Success stories: Several countries (notably Netherlands, Switzerland) have achieved or maintained near-zero gender gaps in HALE, demonstrating that large gaps are not inevitable.

  3. Variation persists: Despite overall improvement, substantial variation remains across countries, with gaps ranging from near zero to over 6 years.

Indicator-Specific Findings

  1. Cardiovascular disease:

    • Declining rates across most countries (success story)

    • Gender gaps narrowing (improvement in men’s cardiovascular health)

    • Declining importance in explaining gender gaps over time

  2. Cancer (Neoplasms):

    • Increasing importance in explaining gender gaps (now dominant factor)

    • Declining rates in many countries (improvements in prevention/treatment)

    • Gender gaps vary by country and cancer type

  3. Suicide:

    • Large gender gaps persist (men have much higher rates)

    • Mixed trends across countries (some improving, some worsening)

    • Critical intervention target given its importance in explaining gaps

  4. Road traffic injuries:

    • Strong declining trends (successful safety interventions)

    • Declining importance in explaining gender gaps

    • Demonstrates that targeted interventions can be effective

  5. Diabetes:

    • Increasing rates in many countries (global epidemic)

    • Requires continued attention and intervention

Policy Implications

  1. Priority interventions:

    • Suicide prevention: Highest potential impact on gender gaps

    • Cancer prevention and treatment: Dominant factor in explaining gaps

    • Unintentional injury prevention: Consistently important across time periods

  2. Success stories to learn from:

    • Cardiovascular disease: Successful prevention and treatment programs

    • Road traffic injuries: Effective safety regulations and infrastructure improvements

    • Countries with near-zero gaps: Netherlands, Switzerland provide models for other countries

  3. Areas of concern:

    • Diabetes: Increasing rates require attention

    • Suicide: Mixed trends suggest need for targeted prevention programs

    • Persistent gaps: Large gender gaps in several indicators suggest need for gender-specific interventions


Notes